Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. apr. Rein Verbeke

Faculty of Pharmaceutical Sciences > Department of Pharmaceutics

Work address: Ottergemsesteenweg 460
9000 Gent
Email: Rein.Verbeke@UGent.be
ORCID iD: 0000-0003-1849-5411

Show Sort by

Add to list
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures

Sofie Meulewaeter (UGent) , Gust Nuytten (UGent) , Miffy H.Y. Cheng, Stefaan De Smedt (UGent) , Pieter R. Cullis, Thomas De Beer (UGent) , Ine Lentacker (UGent) and Rein Verbeke (UGent)

(2023) JOURNAL OF CONTROLLED RELEASE. 357. p.149-160
Add to list
- Journal Article
- A1
- open access
Exciting times for lipid nanoparticles : how Canadian discoveries are enabling gene therapies

Miffy H. Y. Cheng, Cedric A. Brimacombe, Rein Verbeke (UGent) and Pieter R. Cullis

(2022) MOLECULAR PHARMACEUTICS. 19(6). p.1663-1668
Add to list
- Journal Article
- A1
- open access
Innate immune mechanisms of mRNA vaccines

Rein Verbeke (UGent) , Michael J. Hogan, Karin Loré and Norbert Pardi

(2022) IMMUNITY. 55(11). p.1993-2005
Add to list
- Journal Article
- A1
- open access
Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes

Rupert Mayer (UGent) , Rein Verbeke (UGent) , Caroline Asselman (UGent) , Ilke Aernout (UGent) , Adillah Gul (UGent) , Denzel Eggermont (UGent) , Katie Boucher (UGent) , Fabien Henri Thery (UGent) , Teresa Maia (UGent) , Hans Demol (UGent) , et al.

(2022) NATURE COMMUNICATIONS. 13(1).
Add to list
Fluorine MR imaging probes dynamic migratory profiles of perfluorocarbon-loaded dendritic cells after streptozotocin-induced inflammation

Shweta Saini, An-Sofie Vanherwegen, Sayuan Liang, Rein Verbeke (UGent) , Hannelie Korf, Ine Lentacker (UGent) , Stefaan De Smedt (UGent) , Conny Gysemans and Uwe Himmelreich

(2022) MOLECULAR IMAGING AND BIOLOGY. 24(2). p.321-332
Add to list
- Journal Article
- A1
- open access
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across

An-Katrien Minnaert (UGent) , Helena Vanluchene (UGent) , Rein Verbeke (UGent) , Ine Lentacker (UGent) , Stefaan De Smedt (UGent) , Koen Raemdonck (UGent) , Niek Sanders (UGent) and Katrien Remaut (UGent)

(2021) ADVANCED DRUG DELIVERY REVIEWS. 176.
Add to list
- Journal Article
- A4
- open access
Covipendium : information available to support the development of medical countermeasures and interventions against COVID-19

Martine Denis, Valerie Vandeweerd, Rein Verbeke (UGent) , Anne Laudisoit, Tristan Reid, Emma Hobbs, Laure Wynants and Diane Van der Vliet

(2021) TRANSDISCIPLINARY INSIGHTS. 4. p.1-296
Add to list
- Journal Article
- A1
- open access
mRNA-lipid nanoparticle COVID-19 vaccines : structure and stability

Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Rein Verbeke (UGent) , Gideon Kersten, Wim Jiskoot and Daan J. A. Crommelin

(2021) INTERNATIONAL JOURNAL OF PHARMACEUTICS. 601.
Add to list
- Journal Article
- A1
- open access
mRNA in cancer immunotherapy : beyond a source of antigen

Lien Van Hoecke (UGent) , Rein Verbeke (UGent) , Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Karim Vermaelen (UGent) , Karine Breckpot and Sandra Van Lint (UGent)

(2021) MOLECULAR CANCER. 20(1).
Add to list
- Journal Article
- A1
- open access
The dawn of mRNA vaccines : the COVID-19 case

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2021) JOURNAL OF CONTROLLED RELEASE. 333. p.511-520

1
2
3

Next →